Search

This paper examines characteristics of the activity patterns of blind and vision impaired non-driving populations. The employability and movement potential of the disabled non-driving group is evaluated. Survey results of impaired public transit users are reported. Possible assistive technologies to aid in making travel decisions and undertaking travel are discussed. This paper examines characteristics of the activity patterns of blind and vision impaired non-driving populations. The employability and movement potential of the disabled non-driving group is evaluated. Survey results of impaired public transit users are reported. Possible assistive technologies to aid in making travel decisions and undertaking travel are discussed. This paper examines characteristics of the activity patterns of blind and vision impaired non-driving populations. The employability and movement potential of the disabled non-driving group is evaluated. Survey results of impaired public transit users are reported. Possible assistive technologies to aid in making travel decisions and undertaking travel are discussed. This paper examines characteristics of the activity patterns of blind and vision impaired non-driving populations. The employability and movement potential of the disabled non-driving group is evaluated. Survey results of impaired public transit users are reported. Possible assistive technologies to aid in making travel decisions and undertaking travel are discussed. This paper examines characteristics of the activity patterns of blind and vision impaired non-driving populations. The employability and movement potential of the disabled non-driving group is evaluated. Survey results of impaired public transit users are reported. Possible assistive technologies to aid in making travel decisions and undertaking travel are discussed. This paper examines characteristics of the activity patterns of blind and vision impaired non-driving populations. The employability and movement potential of the disabled non-driving group is evaluated. Survey results of impaired public transit users are reported. Possible assistive technologies to aid in making travel decisions and undertaking travel are discussed.

Isavuconazole is a new triazole with an expanded-spectrum and potent activity against moulds and yeasts. It has been authorized for use in adults for the treatment of invasive aspergillosis and for mucormycosis. The only commercially available isavuconazole susceptibility test is the minimum inhibitory concentration (MIC) strip isavuconazole test. The objective of this study was to assess the in vitro activity of isavuconazole using gradient concentration MIC strips, compared with the EUCAST broth microdilution reference method. A total of 147 clinically relevant fungal isolates comprising 120 Aspergillus sp. and 27 Scedosporium apiospermum complex were tested for susceptibility to isavuconazole using the EUCAST broth microdilution method and by the MIC strip isavuconazole test. The percent essential agreement between the two methods was calculated within a 1-fold dilution. The geometric means for the MICs using the EUCAST reference methods and the strip test were respectively: 0.60 mg/l and 0.65 mg/l for A. fumigatus, 0.70 mg/l and 0.77 mg/l for A. flavus, 1.50 mg/l and 1.25 mg/l for A. niger, 0.41 mg/l and 0.38 mg/l for A. terreus, 1.22 mg/l and 1.08 mg/l for S. apiospermum complex. The isavuconazole MIC strips showed good agreement with the EUCAST reference method. Isavuconazole MIC strips could be useful for susceptibility testing of Aspergillus sp. and S. apiospermum complex. [ABSTRACT FROM AUTHOR]

Introduction: Development of cancer after transplantation has rapidly became one of the leading causes of death in kidney transplant recipients with functioning grafts. Anogenital malignant neoplasms may occur with a 14-fold increased incidence, and human papilloma virus (HPV) infection has been recently identified as the leading cause of cervical carcinoma. We report the preliminary findings of a prospective study that evaluated the incidence of HPV infection and cervical carcinoma in a population of kidney transplant recipients., Patients and Methods: The study included 35 female recipients of a deceased donor kidney with at least 6 months of follow-up. All patients underwent a cervicovaginal brushing, an HPV DNA test, and a Papanicolaou test., Results: Twenty-two patients (62.8%) were positive for HPV DNA. Thirteen of 22 HPV DNA-positive recipients (59%) demonstrated a high-risk HPV genotype. No cytologic anomalies were detected in Papanicolaou smears., Conclusions: These preliminary data demonstrated a high incidence of HPV infection in renal transplant recipients. Most of our recipients exhibited a high-risk HPV genotype, which suggests higher aggressiveness of such infection in immunosuppressed patients. The HPV test is useful to monitor patients at higher risk of anogenital malignant neoplasms by identifying the cytologic anomalies at an earlier stage. This ongoing study will investigate the rate of progression of HPV infection and the clinical patterns of HPV-positive cytologic anomalies in renal transplant recipients.